To further validate these findings, we performed repeated injections of CD27+Ly6C− or CD27+Ly6C+ γδ T cells into E0771 tumor-bearing Tcrd−/− mice, then analyzed these cells from tumors (Fig. 6G). This evidence concerns the gene CD27 and neoplasm.